Puma Biotechnology, Inc. SEC filings PBYI
Puma Biotechnology, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 25, 2012. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 1, 2022 | — |
| CORRESP | Letter to the SEC | Jul 28, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2022 | — |
| EFFECT | Filing | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2021 | — |
| CT ORDER | Filing | Mar 19, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| CORRESP | Letter to the SEC | Dec 21, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2018 | — |
| CORRESP | Letter to the SEC | Dec 3, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2018 | — |
| CT ORDER | Filing | Aug 28, 2018 | — |
| CT ORDER | Filing | Jun 14, 2018 | — |
| CT ORDER | Filing | Apr 18, 2018 | — |
| NT 10-K | Filing | Mar 1, 2018 | Dec 31, 2017 |
| CERTNAS | Auto-generated paper document | Dec 30, 2016 | — |
| 8-A12B | Filing | Dec 30, 2016 | — |
| 25 | Filing | Dec 30, 2016 | — |
| CT ORDER | Filing | Oct 4, 2016 | — |
| CT ORDER | Filing | Oct 4, 2016 | — |
| DEFR14A | Filing | May 20, 2016 | — |
| CORRESP | Letter to the SEC | Feb 3, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2016 | — |
| DFAN14A | Filing | Jan 4, 2016 | — |
| DFAN14A | Filing | Dec 14, 2015 | — |
| DFAN14A | Filing | Dec 10, 2015 | — |
| DEFC14A | Filing | Dec 10, 2015 | — |
| CORRESP | Letter to the SEC | Dec 9, 2015 | — |
| PRER14A | Filing | Dec 9, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2015 | — |
| CORRESP | Letter to the SEC | Dec 7, 2015 | — |
| PRER14A | Filing | Dec 7, 2015 | — |
| DFAN14A | Filing | Dec 7, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2015 | — |
| CORRESP | Letter to the SEC | Dec 4, 2015 | — |
| PRER14A | Filing | Dec 4, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2015 | — |
| DFAN14A | Filing | Nov 30, 2015 | — |
| PREC14A | Filing | Nov 23, 2015 | — |
| DEFC14A | Definitive consent statement | Nov 18, 2015 | — |
| PRRN14A | Second revised preliminary consent statement | Nov 17, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2015 | — |
| PRRN14A | Revised preliminary consent statement | Nov 10, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2015 | — |
| DFAN14A | Filing | Nov 3, 2015 | — |
| DFAN14A | Filing | Oct 29, 2015 | — |
| PREC14A | Preliminary consent statement | Oct 28, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 2, 2015 | — |
| CT ORDER | Filing | Dec 19, 2014 | — |
| CORRESP | Letter to the SEC | Dec 18, 2014 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2014 | — |
| DEFR14A | Filing | Jun 4, 2014 | — |
| EFFECT | Filing | Feb 10, 2014 | — |
| EFFECT | Filing | Apr 11, 2013 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBYI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1401667
- Former names
- INNOVATIVE ACQUISITIONS CORP (until Oct 4, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.